From Financial Modeling Prep: 2025-02-12 12:36:00

CVS Health (NYSE:CVS) exceeded Q4 expectations, driving stock up 14% as CEO David Joyner leads a strategic overhaul. Despite a 28% stock drop due to missed targets and rising medical costs post-pandemic, CVS enrolled the most new Medicare members. Revenue hit $97.71 billion, beating estimates, with adjusted EPS at $1.19.



Read more at Financial Modeling Prep:: CVS Surges 14% on Strong Q4 Earnings Amid Turnarou…